Drugs / Initial FCM
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT03803111 | Jan 2021 → Mar 2022 | symptomatic heart failure | Herzzentrum Bremen | Withdrawn | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Initial FCM | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03803111 ↗ |
| Known as | FCM | “Initial intravenous iron supplementation (FCM)” NCT03803111 ↗ |
| Route | Intravenous | “intravenous supplementation with ferric carboxymaltose” NCT03803111 ↗ |